MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma
Clinical trial NCT00059995 · COMPLETED
Trial details
- NCT number
- NCT00059995
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Primary completion
- 2007-10-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.